Discover the story of the Vickers 559, a British supersonic interceptor designed to outpace Soviet bombers. With advanced ...
In an interview on CNBC’s Mad Money, Len Schleifer said Regeneron (REGN) currently has 40 drugs in development representing billions in potential ...
In an interview on CNBC’s Mad Money, Robert Davis said Merck’s (MRK) current pipeline is the most diversified it has been in recent history.
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Jim Cramer, the host of Mad Money, recently highlighted a surge in merger activity, pointing out that we’ve seen a ...
CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...
Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.
Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, ...
Robert Machray, a veteran actor known for roles in Cheers as well as numerous other sitcoms and Broadway shows, died at his ...
Robert Machray, a veteran actor known for roles in Cheers as well as numerous other sitcoms and Broadway shows, died at his ...
Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...
DoubleLine Capital CEO Jeffrey Gundlach believes the Federal Reserve is missing the bigger picture again.